Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

RKIP Inhibitors

RKIP inhibitors, short for Raf kinase inhibitor protein inhibitors, belong to a class of chemical compounds that play a crucial role in modulating intracellular signaling pathways. To understand the significance of RKIP inhibitors, it's essential to first grasp the function of the Raf kinase inhibitor protein (RKIP) itself. RKIP is a critical intracellular regulator, primarily recognized for its ability to inhibit the Raf/MEK/ERK signaling pathway, which is pivotal in cell proliferation, differentiation, and survival. RKIP inhibitors are designed to target and modulate the activity of RKIP, ultimately affecting downstream signaling pathways. These inhibitors can function in several ways, such as preventing the binding of RKIP to its targets or altering its conformation, thus diminishing its inhibitory effect on the Raf/MEK/ERK pathway. By doing so, RKIP inhibitors can influence cellular processes like cell growth, apoptosis, and migration. Research into RKIP inhibitors is ongoing, aiming to better understand their precise mechanisms and potential applications in various diseases.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cell Sheet Migration Inhibitor, Locostatin

133812-16-5sc-203875
10 mg
$222.00
3
(1)

Locostatin functions as a potent inhibitor of cell sheet migration, primarily through its role as a regulator of protein interactions. It selectively disrupts the binding of specific kinases, thereby modulating signaling pathways that govern cellular motility. The compound's unique structural features facilitate its engagement with target proteins, leading to altered phosphorylation states. This modulation can significantly impact cellular dynamics and spatial organization within tissues.

Necrostatin-1

4311-88-0sc-200142
sc-200142A
20 mg
100 mg
$92.00
$336.00
97
(3)

Necrostatin-1 inhibits RIPK1, preventing necroptosis by disrupting RIPK1-RIPK3 interactions. It is a potent RIPK1 kinase inhibitor.

AP 24534

943319-70-8sc-362710
sc-362710A
10 mg
50 mg
$172.00
$964.00
2
(1)

Ponatinib is a multi-kinase inhibitor, including RIPK1, which suppresses RIPK1-mediated signaling,

Dabrafenib

1195765-45-7sc-364477
sc-364477A
sc-364477B
sc-364477C
sc-364477D
5 mg
25 mg
50 mg
100 mg
10 g
$138.00
$255.00
$273.00
$403.00
$12240.00
6
(1)

Dabrafenib, primarily a BRAF inhibitor, also inhibits RIPK1, thereby suppressing RIPK1-mediated necroptosis and inflammation in various pathological conditions.

Emricasan

254750-02-2sc-507387
5 mg
$90.00
(0)

Emricasan, a caspase inhibitor, indirectly inhibits RIPK1 by preventing its cleavage and activation, leading to reduced necroptosis in liver diseases and other conditions.